Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer Grant US-11534431-B2 United States of America 27 Dec 2022
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer Grant US-10864203-B2 United States of America 15 Dec 2020
Fused tricyclic compounds as Raf kinase inhibitors Grant US-10576087-B2 United States of America 03 Mar 2020
Maleate salts of a B-RAF kinase inhibitor, crystalline forms, methods of preparation, and… Application US-10351559-B2 United States of America 16 Jul 2019